FIBROGEN INC - Common Stock, $0.01 par value (FGEN) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q3 2025

Type / Class: Equity / Common Stock, $0.01 par value
Symbol: FGEN on Nasdaq
Shares outstanding: 100,950,119
Price per share: $0.30
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 0
Total reported value: $0
Share change: -15,000
Value change: -$79,500
Number of holders: 0

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ARMISTICE CAPITAL, LLC	8.4%	+24%	$2,210,000	+$442,000	8,500,000	+25%	Armistice Capital, LLC	31 Mar 2025
PRIMECAP MANAGEMENT CO/CA/	4.6%		$1,200,194		4,616,130		PRIMECAP MANAGEMENT CO/CA/	31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of FIBROGEN INC - Common Stock, $0.01 par value (FGEN). This represents 0% of the company’s total 100,950,119 outstanding shares.

Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q3	0	$0	-$79,500			$0.30	0
2025 Q2	15,000	$79,500	-$10,137,367	$0	$0	$5.30	1
2025 Q1	32,974,661	$10,217,322	-$1,814,144	$31,741	$131,917	$0.31	52
2024 Q4	36,247,262	$19,192,190	-$4,584,403	$55,842	$167,345	$0.53	64
2024 Q3	45,933,468	$18,857,141	-$6,430,104	$268,384	$140,567	$0.40	68
2024 Q2	56,536,652	$50,439,294	-$9,050,644	$807,837	$1,881,657	$0.89	102
2024 Q1	61,231,274	$143,890,553	-$17,800,337	$518,880	$3,536,515	$2.35	108
2023 Q4	230,362	$204,170	+$180,677			$0.89	2
2023 Q3	68,325,992	$58,946,543	-$24,567,608	$54,190	$1,667,977	$0.86	105
2023 Q2	75,649,955	$204,257,598	-$172,902,634	$10,311,313	$20,622,520	$2.70	148
2023 Q1	76,353,881	$1,424,754,261	+$29,258,598	$7,029,222	$39,617,046	$18.66	170
2022 Q4	74,827,884	$1,198,637,612	+$35,286,116	$3,066,228	$31,551,390	$16.02	141
2022 Q3	72,144,539	$938,595,860	+$36,200,116	$2,912,000	$26,798,350	$13.01	142
2022 Q2	70,652,213	$746,541,593	+$27,813,010	$2,367,000	$20,989,000	$10.56	142
2022 Q1	67,895,734	$816,513,036	+$18,199,138	$2,515,000	$3,552,000	$12.02	148
2021 Q4	66,183,186	$933,186,606	+$30,915,219	$3,964,000	$4,277,000	$14.10	153
2021 Q3	63,951,657	$653,395,634	-$172,491,173	$4,431,000	$3,663,000	$10.22	153
2021 Q2	67,739,611	$1,803,899,935	-$93,732,428	$52,400,959	$68,077,281	$26.63	171
2021 Q1	71,083,589	$2,467,391,179	-$16,155,075	$29,219,000	$6,921,000	$34.71	191
2020 Q4	71,479,248	$2,651,208,145	+$82,662,629	$25,062,000	$42,523,000	$37.09	199
2020 Q3	68,849,686	$2,832,056,575	+$68,906,276	$21,485,000	$16,338,000	$41.12	203
2020 Q2	67,188,314	$2,722,920,622	+$109,725,641	$17,529,000	$17,004,000	$40.53	186
2020 Q1	62,590,067	$2,174,960,468	+$118,418,567	$16,707,000	$10,324,000	$34.75	178
2019 Q4	61,320,245	$2,630,067,553	+$37,676,826	$21,534,000	$34,336,000	$42.89	205
2019 Q3	60,104,929	$2,222,813,461	-$20,057,604	$14,545,000	$28,722,000	$36.98	200
2019 Q2	61,186,700	$2,763,306,392	+$192,194,652	$15,319,000	$19,179,000	$45.18	184
2019 Q1	57,796,599	$3,141,458,935	+$63,997,259	$93,834,000	$14,604,000	$54.35	216
2018 Q4	56,533,154	$2,616,257,359	-$104,909,609	$18,937,000	$19,923,000	$46.28	189
2018 Q3	55,853,902	$3,393,140,085	-$20,722,241	$26,420,000	$5,085,000	$60.75	181
2018 Q2	55,460,269	$3,471,779,177	+$229,875,607	$27,638,000	$8,288,000	$62.60	187
2018 Q1	53,268,049	$2,460,260,610	+$130,545,301	$24,882,000	$6,401,000	$46.20	188
2017 Q4	50,162,447	$2,377,668,005	+$105,111,370	$22,264,000	$6,326,000	$47.40	182
2017 Q3	47,800,378	$2,566,231,538	+$545,402,062	$30,214,000	$9,987,000	$53.80	175
2017 Q2	37,761,208	$1,219,648,864	+$273,846,852	$10,181,000	$2,373,000	$32.30	144
2017 Q1	30,876,426	$761,101,665	+$114,452,677	$6,421,000	$1,244,000	$24.65	137
2016 Q4	30,136,845	$644,941,993	+$2,902,378	$5,061,000	$2,653,000	$21.40	134
2016 Q3	30,813,510	$637,314,781	-$11,901,310	$2,006,000	$2,508,000	$20.70	130
2016 Q2	31,596,562	$518,493,981	-$37,226,729	$533,000	$661,000	$16.41	142
2016 Q1	32,617,425	$694,190,000	+$21,799,142	$2,996,000	$4,834,000	$21.29	132
2015 Q4	31,270,981	$953,043,246	+$95,747,306	$2,522,000	$2,777,000	$30.47	132
2015 Q3	28,441,718	$623,400,001	+$68,058,670	$1,843,000	$1,997,000	$21.92	115
2015 Q2	24,103,290	$566,345,893	+$212,477,036	$1,086,000	$1,525,000	$23.50	92
2015 Q1	14,284,030	$447,848,602	+$11,939,149			$31.38	73
2014 Q4	14,814,221	$399,875,130	+$388,893,075			$27.34	65